CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/02/2020
Voltar para busca
Dado oficial do USPTO
CANCER SCHMANCER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CANCER SCHMANCER
ST13
US500000076646192Classe
35, 41
Pedido
76646192
Registro
3547214
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
55
Atualização mais recente
05/02/2020
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 41
Data de depósito
06/09/2005
Data de registro
16/12/2008
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/02/2019
Última transação
09/02/2019
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
18/04/2007
Primeiro uso no comércio
18/04/2007
Código do desenho
4
Tipo de titular
01
Localização do titular
Malibu, CA
Examinador
ELTON, DAVID
Unidade examinadora
L60
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Drescher, Fran
Representantes
M. Graham Coleman Davis Wright Tremaine LLP
Classificação técnica
Classes Nice
Classe 35Classe 41
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
promoting public awareness concerning the advancement, use, and availability of medicine and health care to detect cancer early, treat cancer more effectively, prevent cancer, and cure cancer, and also concerning the need for more advancement, use, and availability of medicine and health care to detect cancer early, treat cancer more effectively, prevent cancer, and cure cancer; providing a website featuring content promoting public awareness concerning the advancement, use, and availability of medicine and health care to detect cancer early, treat cancer more effectively, prevent cancer, and cure cancer, and also concerning the need for more advancement, use, and availability of medicine and health care to detect cancer early, treat cancer more effectively, prevent cancer, and cure cancer, specifically in the nature of providing information on the signs and symptoms of cancer, causes of cancer, risk factors for cancer, government funding for cancer, and politicians and their voting records on government funding for cancer, and providing petitions for others to use to leverage government action on cancer; and lobbying services, namely, promoting the interests of those who would benefit from the advancement, use, and availability of medicine and health care to detect cancer early, treat cancer more effectively, prevent cancer, and cure cancer, in the fields of politics, legislation, and regulation
Classe 41
educational and entertainment services, namely, personal appearances and public speaking by a film and television celebrity to promote the advancement, use, and availability of medicine and health care to detect cancer early, treat cancer more effectively, prevent cancer, and cure cancer, and also promote the need for more advancement, use, and availability of medicine and health care to detect cancer early, treat cancer more effectively, prevent cancer, and cure cancer; and providing a website featuring content in the nature of online journals, namely, blogs promoting public awareness concerning the advancement, use, and availability of medicine and health care to detect cancer early, treat cancer more effectively, prevent cancer, and cure cancer, and also concerning the need for more advancement, use, and availability of medicine and health care to detect cancer early, treat cancer more effectively, prevent cancer, and cure cancer
Publicações
Histórico de despachos e eventos da marca no USPTO.
55 publicações encontradas
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/02/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/02/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/02/2020
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/02/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/02/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/02/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/02/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
11/01/2019
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED
19/02/2015
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
19/02/2015
FAXX
FAX RECEIVED
11/12/2014
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/12/2014
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
26/06/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26/06/2014
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
17/06/2014
PAPER RECEIVED
17/06/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
16/12/2008
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
13/11/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/11/2008
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/10/2008
IUAF
USE AMENDMENT FILED
09/10/2008
EISU
TEAS STATEMENT OF USE RECEIVED
09/10/2008
EX1G
SOU EXTENSION 1 GRANTED
08/09/2008
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/09/2008
PGEX
PETITION GRANTED - EXTENSION REQUEST FILED
18/08/2008
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/08/2008
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/08/2008
APET
ASSIGNED TO PETITION STAFF
14/08/2008
PETR
PETITION TO REVIVE-RECEIVED
11/08/2008
FAXX
FAX RECEIVED
11/08/2008
MAB6
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
10/06/2008
ABN6
ABANDONMENT - NO USE STATEMENT FILED
10/06/2008
EXT1
SOU EXTENSION 1 FILED
09/04/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
09/10/2007
PUBO
PUBLISHED FOR OPPOSITION
17/07/2007
NPUB
NOTICE OF PUBLICATION
27/06/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/06/2007
CNEA
EXAMINERS AMENDMENT MAILED
30/05/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/05/2007
XAEC
EXAMINER'S AMENDMENT ENTERED
30/05/2007
CNEA
EXAMINERS AMENDMENT -WRITTEN
30/05/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/05/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2007
ALIE
ASSIGNED TO LIE
08/05/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/04/2007
CNFR
FINAL REFUSAL MAILED
30/10/2006
CNFR
FINAL REFUSAL WRITTEN
28/10/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/10/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/09/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/09/2006
CNRT
NON-FINAL ACTION MAILED
27/03/2006
CNRT
NON-FINAL ACTION WRITTEN
27/03/2006
DOCK
ASSIGNED TO EXAMINER
19/03/2006
NWAP
NEW APPLICATION ENTERED
13/09/2005
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CANCER SCHMANCER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.